Top-quality medical devices help the FDA better protect and promote public health. And one of the top priorities for FDA's medical devices center is a focus on quality.
More specifically, the FDA is working with stakeholders—industry, health care providers, patients, payers, and investors—to build a strong Case for Quality.
This program allows the FDA to identify device manufacturers that consistently produce high-quality devices. By doing so, we can better focus our resources helping other manufacturers raise their level of quality. This program also helps the FDA identify and promote practices that support consistent quality manufacturing, and align our regulatory, enforcement, compliance approaches with those practices.
The FDA launched the Case for Quality in 2011 following an in-depth review of device quality data and feedback from both FDA and industry stakeholders. The FDA's analysis flagged certain widespread or common manufacturing risks that impact product quality. The review also showed manufacturers that focus on and manage those risks often become more productive, receiving fewer complaints, needing to open fewer Corrective and Preventive Actions and investigations, and having lower quality-related product costs than their competitors.
In simple terms, the review identified that an investment in quality has long-term payoffs.
Benefits for Industry, Health Care Providers, and Patients
Focusing on the quality of medical devices is in everyone's best interest.
Medical device manufacturers can reduce costs and increase their profits by focusing on quality measures during medical device design and production. This quality improvement approach pays dividends in customer satisfaction and provides significant competitive advantages. The Case for Quality program helps the FDA and manufacturers understand and sustain the link between a quality improvement approach and the benefits such approach provides.
Increased product quality also benefits hospitals, payers, health care providers, and patients by generating confidence among them that the devices they rely on will perform as intended. Additionally, focusing on quality measures can allow for a smoother submission review process and therefore a faster access to high-quality devices for consumers.
Ultimately, the Case for Quality focuses on objective information about medical device quality; facilitates medical device innovation through data, processes, and analysis of device performance; and fosters strategies that focus stakeholder interactions on device quality.
The Case for Quality consists of three core components:
While the FDA usually evaluates a manufacturer's compliance based on the regulations governing the design and production of devices, the Focus on Quality initiative goes above and beyond by treating compliance attainment as the baseline and by looking for the inclusion of critical-to-quality practices that result in higher quality outcomes. The FDA is working with stakeholders to promote manufacturers' implementation of critical-to-quality practices during device design and production. These practices range from design improvements to meet customer needs to controlling production errors and increasing speed of detection for quality issues. The FDA is also looking for ways to recognize these practices in its own operations.
The FDA Library of Quality Practices helps medical device professionals identify tools for developing and updating their quality approach in the design and manufacturing of medical devices. The development of the FDA Library of Quality Practices enables the FDA and industry partners to leverage existing knowledge and engage collaboratively with the goal of improving device quality. The American Society for Quality (ASQ) and AdvaMed have contributed resources to the library.
Device data is available on open.fda.gov, with the exception of certain information the FDA is prevented by federal law and regulations from disclosing. The FDA receives a broad array of quality-related data, including information from recall and adverse event reports and inspection results. The FDA proposes to leverage this data through multiple strategies that support device quality. For example, to enhance independent analyses by stakeholders, the FDA is publishing our data so that it can be automatically accessed and searched by external analytical tools.
The FDA works with the Medical Device Innovation Consortium (MDIC) and other stakeholders on Case for Quality to approach medical device compliance and quality more collaboratively, and to launch initiatives that vary from our traditional oversight models. As we move forward, we continue discussions with stakeholders at Case for Quality public meetings and forums.
- MDIC Case for Quality Forums
- MDIC Medical Device Quality Metrics Report
- CDRH 2018-2020 Strategic Priorities
- AdvaMed Library of Quality Practices
- ASQ Library of Quality Practices
- Medical Device Innovation Consortium (MDIC) Case for Quality
- Understanding Barriers to Medical Device Quality
- CDRH Transparency: Compliance & Enforcement
1 (800) 638-2041
Information-Medical Devices / Radiation Products
Division of Industry and Consumer Education
CDRH-Center for Devices and Radiological Health
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993